All articles:

Biosimilars, you ain’t seen nothing yet!

According to the IMS Institute, biologics account for 27% of the pharmaceutical sales in the EU and grew at at 5.5% vs. a total market growth of 1.9% between 2012 and 2013.

Read more
30 March 2015